Asthma (severe, persistent, patients aged 6+, adults) - omalizumab (rev TA133, TA201): Royal College of Pathologists

Asthma (severe, persistent, patients aged 6+, adults) - omalizumab (rev TA133, TA201): Royal College of Pathologists

Asthma (severe, persistent, patients aged 6+, adults) - omalizumab (rev TA133, TA201): Royal College of Pathologists
04 March 2013
(79.03 Kb 23 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 01 March 2013